Get the Stockscreener App
16.93
6.61%
1.05
Medifast Inc stock is traded at $16.93, with a volume of 2.48M.
It is up +6.61% in the last 24 hours and up +0.00% over the past month.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.
See More
Previous Close:
$15.88
Open:
$15.71
24h Volume:
2.48M
Relative Volume:
43.83
Market Cap:
$4.75B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$15.67
$17.15
1-Week Range:
$15.40
$17.15
52-Week Range:
$15.40
$17.15
Medifast Inc Stock (MMED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
763-222-9423
Address
18000 DEVONSHIRE ST., NORTHRIDGE
Compare MMED vs ROL, SCI, HRB, FTDR, ANDG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MMED
Medifast Inc
|
16.93 | 4.46B | 0 | 0 | 0 | 0.00 |
ROL
Rollins Inc
|
45.11 | 21.89B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
78.72 | 10.99B | 4.33B | 535.79M | 486.05M | 3.79 |
HRB
H R Block Inc
|
42.08 | 5.30B | 3.91B | 736.10M | 760.88M | 5.6238 |
FTDR
Frontdoor Inc
|
75.69 | 5.33B | 2.12B | 260.00M | 385.00M | 3.5067 |
ANDG
Andersen Group Inc
|
44.45 | 4.83B | 871.37M | -163.01M | 0 | 1.0456 |
Medifast Inc Stock (MMED) Latest News
Medifast launches Trilivy, replacing its Optavia brand - StreetInsider
Medifast rebrands weight loss program as Trilivy By Investing.com - Investing.com Nigeria
Medifast Gains on Trilivy Launch - Baystreet.ca
Medifast rebrands weight loss program as Trilivy - Investing.com India
Medifast Rebrands as Trilivy™: Launches Science-Backed Metabolic Health System for Optimal Wellness 6 - Minichart
Medifast (NYSE: MED) rebrands OPTAVIA as Trilivy metabolic health platform - Stock Titan
Medifast Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System - Business Wire
Medifast (NYSE:MED) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack - TradingView
Medifast Inc (NYSE: MED) director details indirect fund-held share ownership in Form 3/A - Stock Titan
Medifast Inc extends its weight-loss pivot as investors watch for the next strategic move - ad-hoc-news.de
Medifast Essential 4&2&1 Plan Kit from Medifast Inc.structured weight-loss bundle for US dieters - ad-hoc-news.de
3 Reasons MED is Risky and 1 Stock to Buy Instead - The Globe and Mail
Medifast Inc focus on weight-loss programs as industry shifts - ad-hoc-news.de
MEDIFAST Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesEPS Consistency Score - dars.gov.et
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value Benchmark - marketscreener.com
Price to sales forward of MEDIFAST INC – NYSE:MED - TradingView
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Defensive Index - marketscreener.com
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - ad-hoc-news.de
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
MEDIFAST INC (MED) Q1 2026 Earnings: EPS Surprises to the Upside Despite Net Loss; Stock GainsCost Structure Review - dars.gov.et
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast faces challenges with shrinking coach ... - Pluang
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - Yahoo Finance
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Medifast announces CEO succession plan, Johnson named president By Investing.com - Investing.com Nigeria
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026 - Business Wire
Law firm investigates Medifast directors for po... - Pluang
Medifast's New Product Pipeline: Key Catalyst for Comeback? - Yahoo Finance
Investment firm shakes up public company board - The Business Journals
Medifast Announces Cooperation Agreement with Steamboat Capital - Business Wire
Hims and Hers Expands Consumer-Focused Digital Health Platform - TradingView
Weight Loss and Diet Management Analysis Report 2026-2035: A $45+ Billion Market by 2030 with Weight Watchers, Nutrisystem, Kellogg, Herbalife, Apollo Endosurgery, and Medifast Leading - Yahoo Finance UK
Public company to leave Harbor East headquarters - The Business Journals
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Medifast Is A Net-Net With Negative Enterprise Value (NYSE:MED) - Seeking Alpha
Nicholas Johnson - Direct Selling News
Local public company looks beyond weight loss amid revenue decline - The Business Journals
Medifast Stock: Between Obsolescence And Optionality (NYSE:MED) - Seeking Alpha
Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y - Yahoo Finance
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™ - Business Wire
With 78% ownership of the shares, Medifast, Inc. (NYSE:MED) is heavily dominated by institutional owners - Yahoo Finance
Medifast's sales plummeted 60% in 3 years. Is Ozempic to blame? - The Business Journals
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Business Wire
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off - Business Wire
Medifast pivots again as revenue falls by 43% - The Business Journals
Medifast to close Maryland warehouse, lay off 62 workers - The Business Journals
Medifast Inc Stock (MMED) Financials Data
There is no financial data for Medifast Inc (MMED). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.83%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):